Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke
Clinical trial NCT00630396 · COMPLETED
Trial details
- NCT number
- NCT00630396
- Sponsor
- David Hess, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2010-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.